The effect of Paricalcitol is to inhibit the synthesis and secretion of parathyroid hormone and reduce the level of parathyroid hormone.
Paricalcitol is a kind of antiparathyroid drug, the commonly used clinical dosage form for injection, in the human body can be combined with the vitamin D receptor, and vitamin D together to inhibit the synthesis and secretion of parathyroid hormone, clinically used in patients with chronic renal failure who are undergoing hemodialysis, the treatment of secondary hyperparathyroidism.
It should be noted that the use of Paricalcitol is prohibited in patients who are allergic to any component of the drug, hypercalcemia, or vitamin D toxicity. Some patients may experience adverse reactions such as hypercalcemia, hyperphosphatemia, allergy, etc., which should be promptly notified to the doctor and treated accordingly.
Paricalcitol should be used by professional doctors, patients should not use the drug by themselves to avoid affecting the condition, or side effects.